U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Grade 1 Eosinophilia, CTCAE

MedGen UID:
1639867
•Concept ID:
C4685122
•
Finding

Definition

>ULN and >Baseline [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGrade 1 Eosinophilia, CTCAE

Professional guidelines

PubMed

Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R
Acta Trop 2013 Aug;127(2):101-4. Epub 2013 Apr 11 doi: 10.1016/j.actatropica.2013.04.003. PMID: 23583863

Recent clinical studies

Therapy

Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R
Acta Trop 2013 Aug;127(2):101-4. Epub 2013 Apr 11 doi: 10.1016/j.actatropica.2013.04.003. PMID: 23583863

Clinical prediction guides

Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R
Acta Trop 2013 Aug;127(2):101-4. Epub 2013 Apr 11 doi: 10.1016/j.actatropica.2013.04.003. PMID: 23583863

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...